Homeopathy 2016; 105(03): 265-269
DOI: 10.1016/j.homp.2016.04.003
Original Paper
Copyright © The Faculty of Homeopathy 2016

In vitro assessment of anticytotoxic and antigenotoxic effects of CANOVA®

Henrique Fonseca Sousa do Nascimento
1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
,
Plínio Cerqueira dos Santos Cardoso
1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
,
Helem Ferreira Ribeiro
1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
,
Tatiane Cristina Mota
1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
,
Lorena Monteiro Gomes
1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
,
André Salim Khayat
1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
,
Adriana Costa Guimarães
1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
,
Marucia Irena Medeiros Amorim
2   Universidade da Amazônia (UNAMA), Belém, Pará, Brazil
,
Rommel Rodriguéz Burbano
1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
,
Marcelo de Oliveira Bahia
1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received08. April 2015
revised20. Februar 2016

accepted29. Februar 2016

Publikationsdatum:
28. Dezember 2017 (online)

Preview

Background: CANOVA® (CA) is a homeopathic immunomodulator. It contains several homeopathic medicines prepares according to the Brazilian Pharmacopoeia. CA is indicated in clinical conditions in which the immune system is impaired and against tumors. N-methyl-N-nitrosourea (NMU) is an N-nitroso compound, with genotoxic/mutagenic properties. Although several studies have shown promising results in the use of CA, there are no studies reporting possible antigenotoxic effects.

Method: This study evaluated the in vitro antigenotoxic and anticytotoxic effects of CA in human lymphocytes exposed to NMU. Samples of human lymphocytes that were subjected to different concentrations of a mixture containing CA and NMU were used. The genotoxicity/antigenotoxicity of CA was evaluated by the comet assay, anticytotoxicity was assessed by quantification of apoptosis and necrosis using acridine orange/ethidium bromide.

Results: CA significantly reduced DNA damage induced by NMU and reduced significantly the frequency of NMU-induced apoptosis after 24 h of treatment.

Conclusion: CA has an important cytoprotective effect significantly reducing the DNA damage and apoptosis induced by the carcinogen NMU.